Evidence map›Paper›PMID 39192180›Full record

SynthesisBMC infectious diseases2024

Costs of HIV testing services in sub-Saharan Africa: a systematic literature review.

Nurilign Ahmed, Jason J Ong, Kathleen McGee, Marc d'Elbée, Cheryl Johnson, Valentina Cambiano, Karin Hatzold, Elizabeth L Corbett, Fern Terris-Prestholt, Hendramoorthy Maheswaran

Abstract readSystematic Review
In one paragraph

Synthesis in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nurilign AhmedFaculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK. Nurelign.ahmed@gmail.com.ORCID http://orcid.org/0000-0003-3953-7473
Jason J OngFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Kathleen McGeeFaculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK.
Marc d'ElbéeFaculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK.
Cheryl JohnsonFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Valentina CambianoInstitute for Global Health, University College London, London, UK.
Karin HatzoldPopulation Services International, Cape Town, South Africa.
Elizabeth L CorbettFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Fern Terris-PrestholtFaculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK.
Hendramoorthy MaheswaranInstitute of Global Health Innovation, Imperial College London, London, UK.

Funding

World Health Organization 001
6 · The paper itself

Abstract

objectiveTo review HIV testing services (HTS) costs in sub-Saharan Africa.

designA systematic literature review of studies published from January 2006 to October 2020.

methodsWe searched ten electronic databases for studies that reported estimates for cost per person tested ($pptested) and cost per HIV-positive person identified ($ppositive) in sub-Saharan Africa. We explored variations in incremental cost estimates by testing modality (health facility-based, home-based, mobile-service, self-testing, campaign-style, and stand-alone), by primary or secondary/index HTS, and by population (general population, people living with HIV, antenatal care male partner, antenatal care/postnatal women and key populations). All costs are presented in 2019US$.

resultsSixty-five studies reported 167 cost estimates. Most reported only $pptested (90%), while (10%) reported the $ppositive. Costs were highly skewed. The lowest mean $pptested was self-testing at $12.75 (median = $11.50); primary testing at $16.63 (median = $10.68); in the general population, $14.06 (median = $10.13). The highest costs were in campaign-style at $27.64 (median = $26.70), secondary/index testing at $27.52 (median = $15.85), and antenatal male partner at $47.94 (median = $55.19). Incremental $ppositive was lowest for home-based at $297.09 (median = $246.75); primary testing $352.31 (median = $157.03); in the general population, $262.89 (median: $140.13).

conclusionWhile many studies reported the incremental costs of different HIV testing modalities, few presented full costs. Although the $pptested estimates varied widely, the costs for stand-alone, health facility, home-based, and mobile services were comparable, while substantially higher for campaign-style HTS and the lowest for HIV self-testing. Our review informs policymakers of the affordability of various HTS to ensure universal access to HIV testing.

Indexed as

HIV InfectionsHIV TestingAfrica South of the SaharaFemaleHealth Care CostsHumansMaleMass ScreeningSelf-TestingCostCost analysisCostingHIV testing servicesSub-Saharan Africa

Identifiers

PMID39192180
PMCPMC11348535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.